NUV-868
Showing 1 - 9 of 9
Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)
Recruiting
- Advanced Solid Tumor
- +26 more
- NUV-868
- +2 more
-
Baltimore, Maryland
- +3 more
Aug 1, 2022
Type 1 Diabetes Trial in Chula Vista (CT-868, Placebo, Victoza)
Recruiting
- Type 1 Diabetes
- CT-868
- +2 more
-
Chula Vista, CaliforniaCarmot Clinical Research Unit 101
Mar 30, 2023
Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)
Recruiting
- Advanced Breast Cancer
- +7 more
-
Anaheim, California
- +4 more
Apr 6, 2022
Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)
Not yet recruiting
- Prostate Cancer
- +7 more
- (no location specified)
Jan 12, 2022
Obesity, Type2 Diabetes Trial in Mexico, United States (Placebo, CT-868)
Active, not recruiting
- Obesity
- Type2 Diabetes
- Placebo
- CT-868
-
Los Angeles, California
- +5 more
Jul 24, 2022
Diabetes Trial in Chula Vista (CT-868 as SC Injection, Placebo as SC Injection, Active Comparator as SC Injection)
Completed
- Diabetes
- CT-868 as SC Injection
- +2 more
-
Chula Vista, CaliforniaCarmot Clinical Research Unit 101
Apr 30, 2022
Advanced/Metastatic Neuroendocrine Tumors Trial in Spain (Pazopanib)
Completed
- Advanced/Metastatic Neuroendocrine Tumors
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +9 more
May 15, 2019